Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas A Butowski

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Neuro-Oncology|November 2, 2010
Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastomaEmma Essock-Burns, Janine M Lupo, Soonmee Cha, et al.
Neuro-Oncology|May 27, 2010
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiformeInas S Khayal, Mei-Yin C Polley, Llewellyn Jalbert, et al.
Clinical Neurology and Neurosurgery|May 28, 2013
Disseminated progression of glioblastoma after treatment with bevacizumabOrin Bloch, Michael Safaee, Matthew Z Sun, et al.
Journal of Neuro-Oncology|September 12, 2014
Familial gliomas: cases in two pairs of brothersJoseph A Osorio, Shawn L Hervey-Jumper, Kyle M Walsh, et al.
Journal of Neuro-Oncology|December 1, 2018
Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60Ramin A Morshed, Seunggu J Han, Shawn L Hervey-Jumper, et al.
Frontiers in Oncology|August 8, 2022
CDK 4/6 inhibitors for the treatment of meningiomaJacob S Young, Reilly L Kidwell, Allison Zheng, et al.
Journal of Neuro-Oncology|November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant gliomaEdward Pan, Jeffrey G Supko, Thomas J Kaley, et al.
Neuro-Oncology|March 28, 2014
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade gliomaSeunggu J Han, John D Rolston, Annette M Molinaro, et al.
Neurosurgery|April 10, 2015
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed GlioblastomaSeunggu J Han, W Caleb Rutledge, Annette M Molinaro, et al.
Neurosurgery|July 17, 2015
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current EvidenceSeunggu J Han, Dario J Englot, Harjus Birk, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|November 2, 2010
Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastomaEmma Essock-Burns, Janine M Lupo, Soonmee Cha, et al.
Neuro-Oncology|May 27, 2010
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiformeInas S Khayal, Mei-Yin C Polley, Llewellyn Jalbert, et al.
Clinical Neurology and Neurosurgery|May 28, 2013
Disseminated progression of glioblastoma after treatment with bevacizumabOrin Bloch, Michael Safaee, Matthew Z Sun, et al.
Journal of Neuro-Oncology|September 12, 2014
Familial gliomas: cases in two pairs of brothersJoseph A Osorio, Shawn L Hervey-Jumper, Kyle M Walsh, et al.
Journal of Neuro-Oncology|December 1, 2018
Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60Ramin A Morshed, Seunggu J Han, Shawn L Hervey-Jumper, et al.
Frontiers in Oncology|August 8, 2022
CDK 4/6 inhibitors for the treatment of meningiomaJacob S Young, Reilly L Kidwell, Allison Zheng, et al.
Journal of Neuro-Oncology|November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant gliomaEdward Pan, Jeffrey G Supko, Thomas J Kaley, et al.
Neuro-Oncology|March 28, 2014
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade gliomaSeunggu J Han, John D Rolston, Annette M Molinaro, et al.
Neurosurgery|April 10, 2015
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed GlioblastomaSeunggu J Han, W Caleb Rutledge, Annette M Molinaro, et al.
Neurosurgery|July 17, 2015
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current EvidenceSeunggu J Han, Dario J Englot, Harjus Birk, et al.
Pageof 6